Published by Reza Nassab
Mia FemTech is an innovative approach in the field of cosmetic surgery, specifically tailored for breast augmentation developed by Establishment Laboratories who also make Motiva Implant. It stands out from traditional methods by being less invasive, aiming for minimal scarring and a quicker recovery time. The technique combines advanced surgical tools and technologies, enabling surgeons to perform breast augmentations through a smaller incision while maintaining precision and safety. This is just being launched in the UK and the world for the treatment of breast hypoplasia or small breasts.
The Mia FemTech procedure involves several key steps:
The incision is usually in the armpit. The size of the implants that can be used with Mia FemTech depends on the patient’s anatomy and the desired result. Generally, the procedure is only for a small increase in size of about a cup size. If you would like a larger increase in breast size then traditional breast augmentation or MiniAugmentation techniques would provide the desired results.
The Mia FemTech technique, like other medical procedures, has to undergo rigorous scrutiny and approval processes to ensure its safety and efficacy. It is important to verify that any medical technique or device used in the procedure is approved by relevant regulatory bodies, such as the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, and the Food and Drug Administration (FDA) in the USA. Surgeons employing Mia FemTech should be highly trained and experienced in this method to ensure optimal outcomes. Some initial studies have shown early results and these include the following: The Mia Feasibility Clinical Study was a prospective study that enrolled 100 subjects between December 2020 and April 2021. In the preliminary two-year Kaplan-Meier analysis of key events, there were no reports of capsular contracture (Baker Grade III/IV) and no ruptures (suspected or confirmed). Our recommendation when considering any new device or implant is wait until there is much more established data and research. It is still very early stages for the Mia Femtech device which is why we have not started to offer this until there is much more established data.
Mia FemTech differs from traditional breast augmentation in several key ways:
As with any surgical procedure, Mia FemTech carries potential risks and complications, although they may be reduced compared to traditional methods due to the less invasive approach. Potential risks include:
Mia FemTech represents a significant advancement in the field of breast augmentation, offering patients a less invasive option with potentially reduced recovery times and minimal scarring. However, like any surgical procedure, it is not without risks. The technique is in its very early stages and there is not too much scientific evidence published to report safety information. In view of this, I would caution patients seeking this as a first choice procedure. You should book a consultation with us to find out if the traditional or MiniAug breast enhancement options may be safer more established procedures for your desired results.
Your Consultation
Consultations involve an in-depth discussion about your desired outcomes and planning bespoke solutions to address your concerns. Mr. Reza Nassab provides consultations in Cheshire and Manchester. We are committed to delivering the highest quality of care for our patients. Mr. Reza Nassab performs consultations and procedures in Knutsford, Cheshire, and Deansgate Square, Manchester. He operates in the exclusive boutique hospital in Wilmslow, Cheshire. This is a state-of-the-art facility providing the best in patient care. Mr. Reza Nassab provides consultations and minor procedures at CLNQ in Deansgate Square Manchester and Knutsford Cheshire.
Get in touch
Fill out the form below, and we’ll get back to you as soon as possible. Please send me information about your services*